Placing of shares in Navamedic ASA (NO) — NOK 95 million

Carnegie acted as joint bookrunner in the placing of shares in Navamedic, on behalf of Ingerø Reiten Investment Company AS, in the sale of 2,965,618 shares in Navamedic.

Navamedic is a Nordic pharma company and a reliable provider of high-quality products, delivered to hospitals and through pharmacies, meeting the specific needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Sensidose is a pharmaceutical company that has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient.